Stockreport

EXoZymes Inc (EXOZ) Q4 2025 Earnings Call Highlights: Strategic Advances Amid Financial Challenges [Yahoo! Finance]

Invizyne Technologies Inc.  (IZTC) 
PDF Total Operating Expenses: $9.72 million for the year 2025, an increase of $3.78 million from 2024. Net Loss: $9.16 million for the year 2025. Release Date: March 31 [Read more]